Owner Immunomedics, Inc.

Inventors Qu, Zhengxing; McBride, William J.; Griffiths, Gary L.; Goldenberg, David M.; Leung, Shui-on; Hansen, Hans J.

Agent Davies Collison Cave

Pub. Number AU-B-2008201428

Parent 2002256025

Filing date 28 March 2008

Wipo publication date 24 April 2008

Acceptance publication date 11 November 2010

A61B 5/055 (2006.01) Measuring for diagnostic purposes - involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 49/00 (2006.01) Preparations for testing

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

C07K 5/107 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/11 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/44 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material not provided for elsewhere

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies